Safety and Biological Activity of TroVax® Vaccine Given With IL-2 in Renal Cell Carcinoma

NCT00325507 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Renal Cell

Interventions

BIOLOGICAL: TroVax
DRUG: IL-2

Sponsor

Oxford BioMedica

Collaborators

[object Object]
[object Object]